Skip to main content
Log in

Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics

  • REVIEW ARTICLE
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Cancer chemotherapy is known to lead to nausea and vomiting in a large proportion of cases. If emesis is severe it can lead in its turn to anticipatory nausea and vomiting (ANV), which cannot be controlled by antiemetic medication. The etiology of ANV and various methods that have been used to counteract the condition are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morrow, G., Roscoe, J., Kirshner, J. et al. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer 6, 244–247 (1998). https://doi.org/10.1007/s005200050161

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005200050161

Navigation